Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer

BMC Molecular Biology

Volumn 8, Issue , 2007, Pages

  McNeill, Roisin E ^a   Miller, Nicola ^a   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BETA 2 MICROGLOBULIN; BETA GLUCURONIDASE; CYCLOPHILIN A; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE 1; MITOCHONDRIAL RIBOSOME PROTEIN L19; PSMC4 PROTEIN; PUM1 PROTEIN; RIBOSOME PROTEIN; RNA BINDING PROTEIN; RPLP0 PROTEIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; ESR1 PROTEIN, HUMAN; TUMOR MARKER;

ACCURACY; ANALYTICAL ERROR; ARTICLE; BENIGN TUMOR; BREAST CANCER; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC VALUE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; STATISTICAL MODEL; VALIDITY; BREAST TUMOR; EVALUATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 38349106695     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-8-107     Document Type: Article

References (51)

1. Higuchi R Dollinger G Walsh PS Griffith R: Simultaneous amplification and detection of specific DNA sequences. Biotechnology (N Y) 1992, 10(4):413-417. 10.1038/nbt0492-413 1368485
2. Higuchi R Fockler C Dollinger G Watson R: Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N Y) 1993, 11(9):1026-1030. 10.1038/nbt0993-1026 7764001
3. Ginzinger DG: Gene quantification using real-timA quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002, 30(6):503-512. 10.1016/S0301-472X(02)00806-8 12063017
4. Valasek MA Repa JJ: The power of real-time PCR. Adv Physiol Educ 2005, 29(3):151-159. 10.1152/advan.00019.2005 16109794
5. Walker NJ: Tech.Sight. A technique whose time has come. Science 2002, 296(5567):557-559. 10.1126/science.296.5567.557 11964485
6. Perreard L Fan C Quackenbush JF Mullins M Gauthier NP Nelson E Mone M Hansen H Buys SS Rasmussen K Orrico AR Dreher D Walters R Parker J Hu Z He X Palazzo JP Olopade OI Szabo A Perou CM Bernard PS: Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res 2006, 8(2):R23. 1557722 16626501 10.1186/bcr1399
7. Leissner P Verjat T Bachelot T Paye M Krause A Puisieux A Mougin B: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer. BMC Cancer 2006, 6:216. 1564186 16945123 10.1186/1471-2407-6-216
8. Vinatzer U Dampier B Streubel B Pacher M Seewald MJ Stratowa C Kaserer K Schreiber M: Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: Quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Clin Cancer Res 2005, 11(23):8348-8357. 10.1158/ 1078-0432.CCR-05-0841 16322295
9. Span PN Lindberg RL Manders P Tjan-Heijnen VC Heuvel JJ Beex LV Sweep CG: Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol 2004, 202(4):395-402. 10.1002/path.1528 15095266
10. Esteva FJ Sahin AA Cristofanilli M Coombes K Lee SJ Baker J Cronin M Walker M Watson D Shak S Hortobagyi GN: Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res 2005, 11(9):3315-3319. 10.1158/1078-0432.CCR-04-1707 15867229
11. Paik S Shak S Tang G Kim C Baker J Cronin M Baehner FL Walker MG Watson D Park T Hiller W Fisher ER Wickerham DL Bryant J Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351(27):2817-2826. 10.1056/NEJMoa041588 15591335
12. Zhang Z Yamashita H Toyama T Sugiura H Ando Y Mita K Hamaguchi M Hara Y Kobayashi S Iwase H: NCOR1 mRNA is an independent prognostic factor for breast cancer. Cancer Lett 2006, 237(1):123-129. 10.1016/ j.canlet.2005.05.046 16019133
13. Huggett J Dheda K Bustin S Zumla A: Real-time RT-PCR normalisation; strategies and considerations. Genes and immunity 2005, 6(4):279-284. 10.1038/sj.gene.6364190
14. Chang TJ Juan CC Yin PH Chi CW Tsay HJ: Up-regulation of beta-actin, cyclophilin and GAPDH in N1S1 rat hepatoma. Oncol Rep 1998, 5(2):469-471. 9468581
15. Rondinelli RH Epner DE Tricoli JV: Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1997, 1(2):66-72. 10.1038/ sj.pcan.4500208 12496918
16. Weisman AS Tixier-Vidal A Gourdji D: Thyrotropin-releasing hormone increases the levels of c-fos and beta-actin mRNA in GH3/B6 pituitary tumor cells. In Vitro Cell Dev Biol 1987, 23(8):585-590. 10.1007/ BF02620977 3114226
17. Lu S Gu X Hoestje S Epner DE: Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 2002, 1574(2):152-156. 11955624
18. Tokunaga K Nakamura Y Sakata K Fujimori K Ohkubo M Sawada K Sakiyama S: Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987, 47(21):5616-5619. 3664468
19. Goidin D Mamessier A Staquet MJ Schmitt D Berthier-Vergnes O: Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal Biochem 2001, 295(1):17-21. 10.1006/abio.2001.5171 11476540
20. Naora H Naora H: Differential expression patterns of beta-actin mRNA in cells undergoing apoptosis. Biochem Biophys Res Commun 1995, 211(2):491-496. 10.1006/bbrc.1995.1840 7794260
21. Valenti MT Bertoldo F Dalle Carbonare L Azzarello G Zenari S Zanatta M Balducci E Vinante O Lo Cascio V: The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? BMC Cancer 2006, 6:49. 1473200 16515701 10.1186/1471-2407-6-49
22. Naylor MS Stamp GW Balkwill FR: Beta actin expression and organization of actin filaments in colorectal neoplasia. Epithelial Cell Biol 1992, 1(3):99-104. 1307945
23. Kubista M Andrade JM Bengtsson M Forootan A Jonak J Lind K Sindelka R Sjoback R Sjogreen B Strombom L Stahlberg A Zoric N: The real-time polymerase chain reaction. Mol Aspects Med 2006, 27(2-3):95-125. 10.1016/ j.mam.2005.12.007 16460794
24. Vandesompele J De Preter K Pattyn F Poppe B Van Roy N De Paepe A Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7):RESEARCH0034. 126239 12184808 10.1186/gb-2002-3-7-research0034
25. Vandesompele J De Peter K Pattyn F Poppe B Van Roy N De Paepe A Speleman F: GeNorm software manual, update 13th March 2007 http://medgen.ugent.be/ ~jvdesomp/genorm/
26. Andersen CL Jensen JL Orntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64(15):5245-5250. 10.1158/0008-5472.CAN-04-0496 15289330
27. Morse DL Carroll D Weberg L Borgstrom MC Ranger-Moore J Gillies RJ: Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 2005, 342(1):69-77. 10.1016/j.ab.2005.03.034 15958182
28. Szabo A Perou CM Karaca M Perreard L Quackenbush JF Bernard PS: Statistical modeling for selecting housekeeper genes. Genome Biol 2004, 5(8):R59. 507884 15287981 10.1186/gb-2004-5-8-r59
29. Paik S Tang G Shak S Kim C Baker J Kim W Cronin M Baehner FL Watson D Bryant J Costantino JP Geyer CE Jr. Wickerham DL Wolmark N: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24(23):3726-3734. 10.1200/JCO.2005.04.7985 16720680
30. Beillard E Pallisgaard N van der Velden VH Bi W Dee R van der Schoot E Delabesse E Macintyre E Gottardi E Saglio G Watzinger F Lion T van Dongen JJ Hokland P Gabert J: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 2003, 17(12):2474-2486. 10.1038/sj.leu.2403136 14562124
31. Chan MW Wei SH Wen P Wang Z Matei DE Liu JC Liyanarachchi S Brown R Nephew KP Yan PS Huang TH: Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer. Clin Cancer Res 2005, 11(20):7376-7383. 10.1158/1078-0432.CCR-05-1100 16243810
32. Nadano D Sato TA: Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement. J Biol Chem 2000, 275(18):13967-13973. 10.1074/jbc.275.18.13967 10788523
33. White RJ: RNA polymerases I and III, growth control and cancer. Nature reviews 2005, 6(1):69-78. 10.1038/nrm1551 15688068
34. Fleige S Pfaffl MW: RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006, 27(2-3):126-139. 10.1016/ j.mam.2005.12.003 16469371
35. Fleige S Walf V Huch S Prgomet C Sehm J Pfaffl MW: Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006, 28(19):1601-1613. 10.1007/s10529-006-9127-2 16900335
36. Bustin SA Nolan T: Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 2004, 15(3):155-166. 15331581
37. Nolan T Hands RE Bustin SA: Quantification of mRNA using real-time RT-PCR. Nature protocols 2006, 1(3):1559-1582. 10.1038/nprot.2006.236 17406449
38. Yuan JS Reed A Chen F Stewart CN Jr.: Statistical analysis of real-time PCR data. BMC bioinformatics 2006, 7:85. 1395339 16504059 10.1186/ 1471-2105-7-85
39. Aerts JL Gonzales MI Topalian SL: Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques 2004, 36(1):84-6, 88, 90-1 14740490
40. de Kok JB Roelofs RW Giesendorf BA Pennings JL Waas ET Feuth T Swinkels DW: Span PN Normalization of gene expression measurements in tumor tissues: Comparison of 13 endogenous control genes. Laboratory investigation; a journal of technical methods and pathology 2005, 85(1):154-159. 15543203
41. Liu DW Chen ST Liu HP: Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J 2005, 26(6):1002-1008. 10.1183/09031936.05.00050205 16319328
42. Ohl F Jung M Radonic A Sachs M Loening SA Jung K: Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. The Journal of urology 2006, 175(5):1915-1920. 10.1016/S0022-5347(05)00919-5 16600798
43. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25(2):169-193. 10.1677/jme.0.0250169 11013345
44. Pfaffl MW Horgan GW Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002, 30(9):e36. 113859 11972351 10.1093/nar/30.9.e36
45. Perou CM Brown PO Botstein D: Tumor classification using gene expression patterns from DNA microarrays. New technologies for life sciences: A trends guide 2000, Dec:67-76.
46. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Fluge O Pergamenschikov A Williams C Zhu SX Lonning PE Borresen-Dale AL Brown PO Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752. 10.1038/35021093 10963602
47. Tang S Tan SL Ramadoss SK Kumar AP Tang MH Bajic VB: Computational method for discovery of estrogen responsive genes. Nucleic Acids Res 2004, 32(21):6212-6217. 535661 15576347 10.1093/nar/gkh943
48. Bustin SA: Real-time, fluorescence-based qAantitative PCR: a snapshot of current procedures and preferences. Expert review of molecular diagnostics 2005, 5(4):493-498. 10.1586/14737159.5.4.493 16013967
49. Mueller O Lightfoot S Schroeder A RNA integrity number (RIN) - standardization of RNA quality control. Agilent Technologies, Palo Alto 2004
50. geNorm http://medgen.ugent.be/~jvdesomp/genorm/
51. NormFinder http://www.mdl.dk/publicationsnormfinder.htm